Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 21, Issue 3, 2008, Pages 197-207

  Nanovskaya, Tatiana N ^a   Patrikeeva, Svetlana ^a   Hemauer, Sarah ^a   Fokina, Valentina ^a   Mattison, Donald ^b   Hankins, Gary D ^a   Ahmed, Mahmoud S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Gestational diabetes; Glyburide; Rosiglitazone; Transplacental transfer

Indexed keywords

ANTIDIABETIC AGENT; CARBON 14; GLIBENCLAMIDE; HUMAN SERUM ALBUMIN; PHENAZONE; ROSIGLITAZONE; TRITIUM;

CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DRUG ABSORPTION; DRUG BINDING; DRUG DISTRIBUTION; DRUG EFFECT; DRUG RETENTION; EXPERIMENT; FEMALE; FETUS; HUMAN; HUMAN TISSUE; MOTHER; PLACENTA; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

FEMALE; FETAL BLOOD; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MATERNAL-FETAL EXCHANGE; PLACENTAL CIRCULATION; PREGNANCY; SERUM ALBUMIN; THIAZOLIDINEDIONES;

EID: 39749105849     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050801929901     Document Type: Conference Paper

References (23)

1. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991;165:807-812.
2. Elliott BD, Schenker S, Langer O, Johnson R, Prixoda T. Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer. Am J Obstet Gynecol 1994;171:653-660.
3. Nanovskaya TN, Nekhayeva IA, Hankins GD, Ahmed MS. Effect of human serum albumin on transplacental transfer of glyburide. Biochem Pharmacol 2006;72:632-639.
4. Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, Hankins GD, Ahmed MS. Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol 2006;195:1081-1085.
5. Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus. A critical review. Clin Thera 2000;22:1151-1167.
6. Sepilian V, Nagamani M. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrin Metab 2005;90:60-65.
7. Rautio K, Tapanainen JS, Ruokonen A, Morin-Papunen LC. Endocrine and metabolic effects of rosiglitazone on overweight women with PCOS: A randomized placebo-controlled study. Hum Reprod 2006;21:1400-1407.
8. Belli SH, Graggigna MN, Oneto A, Otero P, Schurman L, Levalle OA. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycycstic ovary syndrome. Fertil Steril 2004;81:624-629.
9. Demissie YN, Fiad TM, Klemm K, Twfeeg A, Al-Amoudi A, Meer L, Elhadd TA. Spontaneous singleton and twin pregnancy in two patients with polycystic ovary syndrome and type 2 diabetes following treatment with metformine combined with rosiglitazone. Ann Saudi Med 2006;26:296-299.
10. Yaris F, Yaris E, Kadioglu M, Ulku C, Kesim M, Kalyoncu NI. Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reprod Toxicol 2004;18:619-621.
11. Kalyuncu NI, Yaris F, Ulku C, Kadioglu M, Kesim M, Unsal M, Dikici M, Yaris E. A case of rosiglitazone exposure in the second trimester of pregnancy. Reprod Toxicol 2005;19:563-564.
12. Chan LY, Yeung JH, Lau TK. Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril 2005;83:955-958.
13. Holmes HJ, Casey BM, Bawdon RE. Placental transfer of rosiglitazone in the ex vivo human perfusion model. Am J Obstet Gynecol 2006;195:1715-1719.
14. Miller RK, Wier PJ, Maulik D, di Sant'Agnese PA. Human placenta in vitro: Characterization during 12 h of dual perfusion. Contrib Gynec Obstet 1985;13:77-84.
15. Nanovskaya TN, Deshmukh S, Brooks M, Ahmed M. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002;300:26-33.
16. Mamidi RN, Benjamin B, Ramesh M, Srinivas NR. Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard. Biomed Chromatogr 2003;17:417-420.
17. Langer O. Oral hypoglycemic agents and the pregnant diabetic: "From bench to bedside". Semin Perinatol 2002;26:215-224.
18. Hytten FE, Leitch I. The physiology of human pregnancy. Oxford: Blackwell Scientific Publications; 1971.
19. Pritchard JA, Macdonald PC. Williams' obstetrics, 15th ed. New York: Appleton-Century-Crofts; 1976.
20. Kolte BL, Raut BB, Deo AA, Bagool MA, Shinde DB. Liquid chromatographic method for the determination of rosiglitazone in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2003;788:37-44.
21. Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992;267:4854-4858.
22. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 2006;195:270-274.
23. Gedeon C, Behravan J, Koren G, Piquette-Miller M. Transport of glyburide by placental ABC transporters: Implications in fetal drug exposure. Placenta 2006;27:1096-1102.